Right ventricular fibrosis measured by cardiac MRI in patients with tetralogy of Fallot

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021437

Enrollment

Registered

2020-05-13

Start date

2020-06-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q21.3 I49.9

Interventions

Group 1: Unrepaired patients with Tetralogy of fallot will recieve a cardiac MRI before and 3 months after repair operation, including T1 mapping and tissue phase mapping sequences to visualise fibros

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Informed consent of the patient or guardian, Tetralogy of Fallot, no further severe cardiac defects, planned operation or catheter intervention

Exclusion criteria

Exclusion criteria: Cardiorespiratory instability, typical contraindications against MRI-measurements

Design outcomes

Primary

Measure	Time frame
T1 mapping values and calculated extracellular volume fraction (= fibrosis) in cardiac MRI of right ventricle	—

Secondary

Measure	Time frame
Tissue phase mapping values in cardiac MRI as expression of right ventricular contractility	—

Countries

Germany

Contacts

Public ContactHannah Kappler

Universitäts-Herzzentrum Freiburg - Bad Krozingen, Klinik für Angeborene Herzfehler und Pädiatrische Kardiologie

hannah.kappler@uniklinik-freiburg.de+49 761 27043230

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026